Valuation: Photocure ASA

Market Cap 1.13B 118M 107M 98.62M 89.26M 168M 11.11B 173M 1.18B 470M 5.94B 443M 434M 18.9B P/E 2026 *
15x
P/E 2027 * 74.5x
Enterprise Value 999M 104M 94.37M 87.11M 78.85M 149M 9.81B 153M 1.05B 416M 5.24B 392M 383M 16.69B EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.45x
Free-Float
95.71%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-5.63%
Current month-9.80%
1 month-15.35%
3 months-20.49%
6 months-33.60%
Current year-41.32%
1 week 41.5
Extreme 41.5
44.85
1 month 41.5
Extreme 41.5
50.8
Current year 41.5
Extreme 41.5
79.8
1 year 41.5
Extreme 41.5
79.8
3 years 41.5
Extreme 41.5
79.8
5 years 40.7
Extreme 40.7
122.7
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/25 BuyCompany 11,355 0.0419%
4/2/25 BuyCompany 8,997 0.0332%
3/31/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-5.63%-28.62%-20.49% 118M
+0.03%+5.96%+42.07%+136.00% 1,280B
+1.19%+4.46%+46.34%+92.69% 675B
+0.14%+2.65%+26.87%+113.42% 521B
+1.14%+3.78%+39.98%+70.26% 386B
+0.51%+0.78%+61.94%+44.52% 363B
+1.11%+0.07%+28.19%+58.61% 301B
+0.24%-0.80%+3.05%+35.93% 286B
+0.22%+2.04%+39.67%+76.12% 253B
+0.01%+1.32%+37.59%+126.58% 211B
Average +0.47%-1.13%+29.71%+73.37% 428B
Weighted average by Cap. +0.50%+0.20%+38.43%+96.56%

Financials

2026 *2027 *
Net sales 696M 72.68M 65.73M 60.67M 54.92M 104M 6.83B 107M 728M 289M 3.65B 273M 267M 11.63B 668M 69.72M 63.05M 58.2M 52.68M 99.41M 6.55B 102M 699M 278M 3.5B 262M 256M 11.15B
Net income 52M 5.43M 4.91M 4.53M 4.1M 7.74M 510M 7.97M 54.41M 21.62M 273M 20.38M 19.95M 869M 15M 1.57M 1.42M 1.31M 1.18M 2.23M 147M 2.3M 15.69M 6.24M 78.73M 5.88M 5.75M 251M
Net Debt -132M -13.78M -12.47M -11.51M -10.42M -19.65M -1.3B -20.24M -138M -54.89M -693M -51.74M -50.63M -2.21B -166M -17.34M -15.68M -14.47M -13.1M -24.72M -1.63B -25.46M -174M -69.02M -871M -65.06M -63.67M -2.77B
Projected Income Statement - Annual - Photocure ASA
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-11-12 NOK 41.90 -0.12% 94,840
26-11-11 NOK 41.95 +0.36% 96,748
26-11-10 NOK 41.80 -0.71% 99,801
26-11-09 NOK 42.10 -5.61% 199,502
26-11-06 NOK 44.60 +0.45% 126,301
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Photocure ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
41.95NOK
Average target price
75.00NOK
Spread / Average Target
+78.78%